A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a...
Vous n'êtes pas connecté
Ad hoc announcement pursuant to Art. 53 LR Nemluvio® (nemolizumab) is the first approved monoclonal antibody specifically inhibiting the signaling of IL-31, a neuroimmune cytokine that drives multiple disease mechanisms in prurigo nodularis1-3 Prurigo nodularis is a chronic skin condition that is estimated to affect up to 181,000 people in the United States, and […]
A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a...
WEDNESDAY, Sept. 4, 2024 -- The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand,...
THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...
Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious...
Competitive: Galderma: With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the leading company solely...
Competitive: Stanford University (US): The primary aim of the Neuroimmune Imaging Research and Discovery (NiRD) Lab is to improve the diagnosis and...
A new study from researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC), USA, sheds light on why certain...